Anthem Biosciences Ltd Annually Results

Gross Sales

1,844.55

1,419.37

1,056.92

Excise Duty

0

0

0

Net Sales

1,844.55

1,419.37

1,056.92

Other Operating Income

0

0

0

Other Income

85.73

63.7

138.87

Total Income

1,930.29

1,483.07

1,195.79

Total Expenditure

1,173.72

914.39

628.04

PBIDT

756.57

568.68

567.76

Interest

10.33

9.54

6.76

PBDT

746.24

559.14

560.99

Depreciation

89.37

81.82

63.7

Minority Interest Before NP

0

0

0

Tax

182.03

126.41

120.05

Deferred Tax

23.58

-16.4

-7.94

Reported Profit After Tax

451.26

367.31

385.19

Minority Interest After NP

0

0

0

Net Profit after Minority Interest

451.26

367.31

385.19

Extra-ordinary Items

0

0

46.88

Adjusted Profit After Extra-ordinary item

451.26

367.31

338.31

EPS (Unit Curr.)

8.07

6.48

6.75

Book Value (Unit Curr.)

0

0

0

Dividend (%)

0

0

0

Equity

111.82

111.82

114.1

Public Shareholding (Number)

0

0

0

Public Shareholding (%)

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

Non Encumbered - No. of Shares

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

Non Encumbered - % in Total Equity

0

0

0

PBIDTM(%)

41.01

40.06

53.71

PBDTM(%)

40.45

39.39

53.07

PATM(%)

24.46

25.87

36.44